首页|卡维地洛联合贝那普利治疗老年高血压合并心力衰竭患者的效果

卡维地洛联合贝那普利治疗老年高血压合并心力衰竭患者的效果

扫码查看
目的:观察卡维地洛联合贝那普利治疗老年高血压合并心力衰竭患者的效果.方法:选取 2018 年 1 月至 2023 年 3 月该院收治的 150 例老年高血压合并心力衰竭患者进行前瞻性研究,按照随机数字表法将其分为研究组与对照组各 75 例.对照组采用贝那普利治疗,研究组在对照组基础上联合卡维地洛治疗,比较两组临床疗效,治疗前后心功能指标[左心室射血分数(LVEF)、左心室收缩末期内径(LVESD)、左心室舒张末期内径(LVEDD)]水平、血管内皮功能指标[内皮素-1(ET-1)、同型半胱氨酸(Hcy)]水平、血压水平,以及不良反应发生率.结果:研究组治疗总有效率为92.00%(69/75),高于对照组的80.00%(60/75),差异有统计学意义(P<0.05);治疗后,两组LVEF水平均高于治疗前,且研究组高于对照组,两组LVESD、LVEDD水平均低于治疗前,且研究组低于对照组,差异有统计学意义(P<0.05);两组ET-1、Hcy水平均低于治疗前,且研究组低于对照组,差异有统计学意义(P<0.05);两组收缩压、舒张压水平均低于治疗前,且研究组低于对照组,差异有统计学意义(P<0.05);两组不良反应发生率比较,差异无统计学意义(P>0.05).结论:卡维地洛联合贝那普利治疗老年高血压合并心力衰竭患者可提高临床疗效,改善心功能指标水平,降低血管内皮功能指标和血压水平,其效果优于单纯贝那普利治疗.
Effects of Carvedilol combined with Benazepril in treatment of elderly patients with hypertension complicated with heart failure
Objective:To observe effects of Carvedilol combined with Benazepril in treatment of elderly patients with hypertension complicated with heart failure.Methods:A prospective study was conducted on 150 elderly patients with hypertension with heart failure admitted to the hospital from January 2018 to March 2023.According to the random number table method,they were divided into study group and control group,75 cases in each group.The control group was treated with Benazepril,while the study group was treated with Carvedilol on the basis of that of the control group.The clinical efficacy,the levels of cardiac function indexes[left ventricular ejection fraction(LVEF),left ventricular end-systolic diameter(LVESD),left ventricular end-diastolic diameter(LVEDD)],vascular endothelial function indexes[endothelin-1(ET-1),homocysteine(Hcy)]and blood pressure before and after the treatment,and the incidence of adverse reactions were compared between the two groups.Results:The total effective rate of the study group was 92.00%(69/75),which was higher than 80.00%(60/75)of the control group,and the difference was statistically significant(P<0.05).After the treatment,the LVEF levels of the two groups were higher than those before the treatment,and that in the study group was higher than that in the control group;the levels of LVESD and LVEDD in the two groups were lower than those before the treatment,and those in the study group were lower than those in the control group;and the differences were statistically significant(P<0.05).The levels of ET-1 and Hcy in the two groups were lower than those before the treatment,those in the study group were lower than those in the control group,and the differences were statistically significant(P<0.05).The levels of systolic blood pressure and diastolic blood pressure in the two groups were lower than those before the treatment,those in the study group were lower than those in the control group,and the differences were statistically significant(P<0.05).However,there was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusions:Carvedilol combined with Benazepril in the treatment of the elderly patients with hypertension with heart failure can improve the clinical efficacy,improve the levels of cardiac function indexes,and reduce the levels of vascular endothelial function indexes and blood pressure.Moreover,it is superior to single Benazepril treatment.

CarvedilolBenazeprilElderlyHypertensionHeart failureCardiac functionVascular endothelial functionBlood pressure

魏丽琴

展开 >

清丰新兴医院内科一病区,河南 濮阳 457300

卡维地洛 贝那普利 老年 高血压 心力衰竭 心功能 血管内皮功能 血压

2024

中国民康医学
中国社会工作协会

中国民康医学

影响因子:0.649
ISSN:1672-0369
年,卷(期):2024.36(12)
  • 11